Keyword: New York

Takeda and NY biotech Ovid ink rare drug development pact

Takeda, pushing on with its U.S. biotech R&D odyssey, has signed a research deal and collab with New York’s private biotech Ovid that will see the small company work on the Japanese pharma’s new candidate for a rare form of childhood epilepsy.